Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Muller

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The International Journal of Biological Markers|August 3, 2010
IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factorsEmilio Fiore, Daniela Campani, Ilaria Muller, et al.
The Lancet. Diabetes & Endocrinology|December 23, 2018
Liothyronine cost and prescriptions in EnglandPeter N Taylor, Salman Razvi, Ilaria Muller, et al.
International Journal of Molecular Sciences|November 11, 2022
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic ReviewNadia Sawicka-Gutaj, Dawid Gruszczyński, Natalia Zawalna, et al.
International Journal of Molecular Sciences|June 2, 2019
Role of Hyaluronan in Human Adipogenesis: Evidence from in-Vitro and in-Vivo StudiesNicholas Wilson, Robert Steadman, Ilaria Muller, et al.
European Thyroid Journal|March 12, 2024
Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximabIlaria Muller, Sara Maioli, Mirco Armenti, et al.
Nature Reviews. Endocrinology|January 1, 2020
New insights into the pathogenesis and nonsurgical management of Graves orbitopathyPeter N Taylor, Lei Zhang, Richard W J Lee, et al.
European Thyroid Journal|September 5, 2017
TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)Ilaria Muller, Lucy S Kilburn, Peter N Taylor, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2020
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' OrbitopathyGuia Vannucchi, Irene Campi, Danila Covelli, et al.
Frontiers in Genetics|April 4, 2022
Case Report: A Novel ARMC5 Germline Mutation in a Patient with Primary Bilateral Macronodular Adrenal Hyperplasia and HypogammaglobulinemiaWalter Vena, Valentina Morelli, Maria Carrabba, et al.
Scientific Reports|June 1, 2018
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathyLei Zhang, Giulia Masetti, Giuseppe Colucci, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|August 3, 2010
IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factorsEmilio Fiore, Daniela Campani, Ilaria Muller, et al.
The Lancet. Diabetes & Endocrinology|December 23, 2018
Liothyronine cost and prescriptions in EnglandPeter N Taylor, Salman Razvi, Ilaria Muller, et al.
International Journal of Molecular Sciences|November 11, 2022
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic ReviewNadia Sawicka-Gutaj, Dawid Gruszczyński, Natalia Zawalna, et al.
International Journal of Molecular Sciences|June 2, 2019
Role of Hyaluronan in Human Adipogenesis: Evidence from in-Vitro and in-Vivo StudiesNicholas Wilson, Robert Steadman, Ilaria Muller, et al.
European Thyroid Journal|March 12, 2024
Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximabIlaria Muller, Sara Maioli, Mirco Armenti, et al.
Nature Reviews. Endocrinology|January 1, 2020
New insights into the pathogenesis and nonsurgical management of Graves orbitopathyPeter N Taylor, Lei Zhang, Richard W J Lee, et al.
European Thyroid Journal|September 5, 2017
TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)Ilaria Muller, Lucy S Kilburn, Peter N Taylor, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2020
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' OrbitopathyGuia Vannucchi, Irene Campi, Danila Covelli, et al.
Frontiers in Genetics|April 4, 2022
Case Report: A Novel ARMC5 Germline Mutation in a Patient with Primary Bilateral Macronodular Adrenal Hyperplasia and HypogammaglobulinemiaWalter Vena, Valentina Morelli, Maria Carrabba, et al.
Scientific Reports|June 1, 2018
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathyLei Zhang, Giulia Masetti, Giuseppe Colucci, et al.
Pageof 4